Suzanne Craft

49.3k total citations · 15 hit papers
337 papers, 27.9k citations indexed

About

Suzanne Craft is a scholar working on Physiology, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Suzanne Craft has authored 337 papers receiving a total of 27.9k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Physiology, 86 papers in Psychiatry and Mental health and 58 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Suzanne Craft's work include Alzheimer's disease research and treatments (82 papers), Dementia and Cognitive Impairment Research (72 papers) and Diet and metabolism studies (59 papers). Suzanne Craft is often cited by papers focused on Alzheimer's disease research and treatments (82 papers), Dementia and Cognitive Impairment Research (72 papers) and Diet and metabolism studies (59 papers). Suzanne Craft collaborates with scholars based in United States, Canada and United Kingdom. Suzanne Craft's co-authors include G. Stennis Watson, Laura D. Baker, Brenna Cholerton, Stephen R. Plymate, Derek Kellar, Mark A. Reger, Murray A. Raskind, Bryan J. Neth, Elaine R. Peskind and Monique M. Cherrier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Suzanne Craft

320 papers receiving 27.2k citations

Hit Papers

Brain insulin resistance in ty... 2004 2026 2011 2018 2018 2011 2010 2007 2004 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
    2018 1.1k citations Suzanne Craft et al. profile →
  2. Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
    2011 992 citations Suzanne Craft Archives of Neurology profile →
  3. Effects of Aerobic Exercise on Mild Cognitive Impairment
    2010 899 citations Laura D. Baker, Pattie S. Green et al. Archives of Neurology profile →
  4. Intranasal insulin improves cognition and modulates β-amyloid in early AD
    2007 660 citations G. Stennis Watson, Laura D. Baker et al. profile →
  5. Insulin and neurodegenerative disease: shared and specific mechanisms
    2004 656 citations Suzanne Craft, G. Stennis Watson profile →
  6. Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches
    2020 557 citations Suzanne Craft et al. profile →
  7. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
    2006 548 citations Suzanne Craft et al. profile →
  8. Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype
    2005 541 citations G. Stennis Watson, Laura D. Baker et al. profile →
  9. Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes
    2010 515 citations Laura D. Baker, G. Stennis Watson et al. Archives of Neurology profile →
  10. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment
    2019 471 citations Bryan J. Neth, Suzanne Craft et al. profile →
  11. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
    2014 451 citations Suzanne Craft, Thomas J. Montine et al. Alzheimer s & Dementia profile →
  12. Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia
    2015 370 citations Amy Claxton, Laura D. Baker et al. Journal of Alzheimer s Disease profile →
  13. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
    2017 359 citations Timothy M. Hughes, Suzanne Craft et al. profile →
  14. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
    2020 266 citations Suzanne Craft, Rema Raman et al. profile →
  15. Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
    2023 149 citations Mitzi M. Gonzales, Valentina R. Garbarino et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Craft United States 89 12.8k 5.9k 5.9k 4.7k 4.5k 337 27.9k
Lenore J. Launer United States 111 13.0k 1.0× 4.1k 0.7× 3.4k 0.6× 6.6k 1.4× 13.2k 2.9× 612 43.4k
Elaine R. Peskind United States 87 7.9k 0.6× 4.8k 0.8× 1.6k 0.3× 2.8k 0.6× 5.6k 1.2× 294 23.0k
Ralph N. Martins Australia 88 15.6k 1.2× 7.1k 1.2× 1.9k 0.3× 4.0k 0.8× 8.6k 1.9× 591 29.3k
Murray A. Raskind United States 88 6.7k 0.5× 3.3k 0.6× 1.9k 0.3× 2.0k 0.4× 5.1k 1.1× 277 22.6k
Steven E. Arnold United States 89 10.1k 0.8× 5.3k 0.9× 1.4k 0.2× 4.1k 0.9× 7.8k 1.7× 344 28.1k
Phillip A. Low United States 99 11.1k 0.9× 3.4k 0.6× 2.2k 0.4× 3.8k 0.8× 1.9k 0.4× 457 35.7k
Johannes Kornhuber Germany 79 7.4k 0.6× 8.7k 1.5× 1.0k 0.2× 3.1k 0.7× 4.9k 1.1× 852 26.3k
Eva L. Feldman United States 105 16.3k 1.3× 11.0k 1.9× 8.3k 1.4× 3.7k 0.8× 780 0.2× 573 41.5k
Richard Mayeux United States 106 21.3k 1.7× 8.3k 1.4× 3.2k 0.5× 7.3k 1.6× 19.9k 4.4× 518 52.7k
Miia Kivipelto Sweden 80 10.2k 0.8× 3.2k 0.5× 1.3k 0.2× 3.3k 0.7× 9.8k 2.2× 434 26.7k

Countries citing papers authored by Suzanne Craft

Since Specialization
Citations

This map shows the geographic impact of Suzanne Craft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Craft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Craft more than expected).

Fields of papers citing papers by Suzanne Craft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Craft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Craft. The network helps show where Suzanne Craft may publish in the future.

Co-authorship network of co-authors of Suzanne Craft

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Craft. A scholar is included among the top collaborators of Suzanne Craft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Craft. Suzanne Craft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Ashish, et al.. (2025). Neuron‐derived extracellular vesicles as a liquid biopsy for brain insulin dysregulation in Alzheimer's disease and related disorders. Alzheimer s & Dementia. 21(2). e14497–e14497. 8 indexed citations
2.
Gajera, Chandresh R., Thanaphong Phongpreecha, Jacob D. Negrey, et al.. (2025). Mediterranean vs. Western diet effects on the primate cerebral cortical pre‐synaptic proteome: Relationships with the transcriptome and multi‐system phenotypes. Alzheimer s & Dementia. 21(3). e70041–e70041.
3.
Batra, Richa, Bryan J. Neth, Cameron Martino, et al.. (2024). Serum and CSF metabolomics analysis shows Mediterranean Ketogenic Diet mitigates risk factors of Alzheimer’s disease. PubMed. 2(1). 15–15. 14 indexed citations
4.
Mahapatra, Gargi, Zhengrong Gao, Samuel N. Lockhart, et al.. (2024). Peripheral Blood Cells From Older Adults Exhibit Sex-Associated Differences in Mitochondrial Function. The Journals of Gerontology Series A. 79(5). 3 indexed citations
5.
Gaussoin, Sarah A., Melissa M. Rundle, Mark A. Espeland, et al.. (2024). Examining a Preclinical Alzheimer’s Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers. Journal of Alzheimer s Disease. 99(2). 679–691. 1 indexed citations
6.
Register, Thomas C., Jacob D. Negrey, Noah Snyder‐Mackler, et al.. (2024). Relationships between Circulating Monocyte and Brain Transcriptional Profiles in Nonhuman Primates Consuming Mediterranean versus Western Like Diets. Alzheimer s & Dementia. 20(S1). e093067–e093067. 1 indexed citations
7.
Orr, Miranda E., et al.. (2024). PET Imaging of Microtubules in Cognitively Impaired and Normal Older Adults. Alzheimer s & Dementia. 20(S8). 1 indexed citations
8.
Harrison, W.T.A., J. Mark Cline, David L. Caudell, et al.. (2024). Alzheimer disease-like neuropathologic changes in a geriatric baboon (Papio hamadryas). Journal of Veterinary Science. 25(5). e60–e60. 1 indexed citations
9.
Sai, Kiran Kumar Solingapuram, et al.. (2024). First Biodistribution Study of [68Ga]Ga-NOTA-Insulin Following Intranasal Administration in Adult Vervet Monkeys. Journal of Alzheimer s Disease. 101(1). 309–320. 3 indexed citations
10.
Donohue, Michael, Oliver Langford, Philip S. Insel, et al.. (2023). Natural cubic splines for the analysis of Alzheimer's clinical trials. Pharmaceutical Statistics. 22(3). 508–519. 9 indexed citations
11.
Negrey, Jacob D., Suzanne Craft, Thomas C. Register, et al.. (2023). Executive function mediates age-related variation in social integration in female vervet monkeys (Chlorocebus sabaeus). GeroScience. 46(1). 841–852. 6 indexed citations
12.
Craft, Suzanne, et al.. (2023). Targeting immunometabolic pathways for combination therapy in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 9(4). e12423–e12423. 9 indexed citations
13.
14.
Craft, Suzanne, et al.. (2023). Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents. Pharmaceuticals. 16(4). 495–495. 4 indexed citations
15.
Craft, Suzanne, Mark G. Baxter, Matthew J. Jorgensen, et al.. (2021). Temporal emergence of age-associated changes in cognitive and physical function in vervets (Chlorocebus aethiops sabaeus). GeroScience. 43(3). 1303–1315. 11 indexed citations
16.
Gonzales, Mitzi M., Sudarshan Krishnamurthy, Valentina R. Garbarino, et al.. (2021). A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials. Mechanisms of Ageing and Development. 200. 111589–111589. 19 indexed citations
17.
Hanson, Angela J., Laura D. Baker, Brenna Cholerton, et al.. (2015). Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ 4 Carriers and Adults with MildCognitive Impairment. Journal of Alzheimer s Disease. 48(1). 205–218. 39 indexed citations
18.
Craft, Suzanne, Amy Claxton, Angela J. Hanson, et al.. (2014). F1‐02‐04: THERAPEUTIC EFFECTS OF INTRANASAL INSULIN AND INSULIN ANALOGUES ON COGNITION AND MRI MEASURES IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 10(4S_Part_1). 3 indexed citations
19.
Fishel, Mark A., G. Stennis Watson, Thomas J. Montine, et al.. (2005). Hyperinsulinemia Provokes Synchronous Increases in Central Inflammation and β-Amyloid in Normal Adults. Archives of Neurology. 62(10). 1539–44. 179 indexed citations
20.
Craft, Suzanne, Monica L. Gourovitch, & S. Bruce Dowton. (1990). Lateralized deficits in visual attention in early treated pku. Journal of Clinical and Experimental Neuropsychology. 12(1). 78. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lenore J. Launer Breakdown of academic impact, for papers by Elaine R. Peskind Breakdown of academic impact, for papers by Ralph N. Martins Breakdown of academic impact, for papers by Murray A. Raskind Breakdown of academic impact, for papers by Steven E. Arnold Breakdown of academic impact, for papers by Phillip A. Low Breakdown of academic impact, for papers by Johannes Kornhuber Breakdown of academic impact, for papers by Eva L. Feldman Breakdown of academic impact, for papers by Richard Mayeux Breakdown of academic impact, for papers by Miia Kivipelto
Rankless by CCL
2026